- Home
- PLUG vs BHC Comparison
PLUG vs BHC Comparison
Compare PLUG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUG | BHC |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLUG | BHC |
|---|---|---|
| Price | $2.22 | $7.05 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 2 |
| Target Price | $2.15 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 117.2M | 2.8M |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $676,169,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $13.86 | $6.81 |
| Revenue Next Year | $21.99 | $4.11 |
| P/E Ratio | ★ N/A | $7.27 |
| Revenue Growth | 2.53 | ★ 5.86 |
| 52 Week Low | $0.69 | $4.25 |
| 52 Week High | $4.58 | $8.69 |
Technical Indicators
Market Signals| Indicator | PLUG | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.45 | 61.60 |
| Support Level | $1.89 | $6.14 |
| Resistance Level | $2.05 | $7.33 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 51.94 | 78.87 |
Price Performance
Historical ComparisonAbout PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.